Search results for "survival analysi"

showing 10 items of 752 documents

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

2015

Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac abnormalities at some point during the progression of their disease, the most common of which is heart blockage of varying degrees. Such blockage is characterized by conduction defects and supraventricular and ventricular tachycardia, and carries a high risk of sudden cardiac death. Despite its importance, very few animal model studies have focused on the heart dysfunction in DM1. Here, we describe the characterization of the heart phenotype in a Drosophila model expressing pure expanded CUG repeats under the control of the cardiomyocyte-specific driver GMH5-Gal4. Morphologically, expression of 250 CUG repeat…

[SDV]Life Sciences [q-bio]Myotonic dystrophyMedicine (miscellaneous)lcsh:MedicineVentricular tachycardiaImmunology and Microbiology (miscellaneous)DiastoleHeart RateDrosophila ProteinsMyocytes CardiacGeneticsbiologyRNuclear ProteinsHeartPhenotype3. Good healthCell biology[SDV] Life Sciences [q-bio]Drosophila melanogasterPhenotypeDrosophilaDrosophila melanogasterDrosophila ProteinResearch Articlelcsh:RB1-214congenital hereditary and neonatal diseases and abnormalitiesSystoleLongevityNeuroscience (miscellaneous)In situ hybridizationMyotonic dystrophyGeneral Biochemistry Genetics and Molecular BiologyMuscleblindContractilitymedicinelcsh:PathologyAnimalsPentamidineHeart dysfunctionfungilcsh:RArrhythmias Cardiacbiology.organism_classificationmedicine.diseaseMyocardial ContractionSurvival AnalysisDisease Models AnimalTrinucleotide repeat expansionTrinucleotide Repeat Expansion
researchProduct

Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizu…

2017

Immune-checkpoint inhibitors represent the new standard of care in patients with advanced NSCLC who progressed after first-line treatment. This work aim to assess any difference in both efficacy and safety profiles among Nivolumab, Pembrolizumab and Atezolizumab in pre-treated NSCLC patients. Randomized clinical trials comparing immune-checkpoint inhibitor versus docetaxel in pre-treated patients with advanced NSCLC were included and direct comparison meta-analysis of selected trials have been performed. Subsequently the summary estimates of Nivolumab, Pembrolizumab and Atezolizumab emerging from the direct meta-analysis were selected to provide the pooled estimates of hazard ratio (HR) and…

atezolizumabCancer ResearchLung NeoplasmsAntineoplastic AgentsDocetaxelAntibodies Monoclonal HumanizedNSCLCClinical Trials Phase II as TopicCostimulatory and Inhibitory T-Cell ReceptorsCarcinoma Non-Small-Cell LungPDL1HumansRandomized Controlled Trials as TopicnivolumabIncidenceAntibodies MonoclonalPneumoniaSurvival AnalysisPD1Treatment OutcomeClinical Trials Phase III as TopicOncologyimmune-checkpointTaxoidsatezolizumab; immune-checkpoint; nivolumab; NSCLC; PD1; PDL1; pembrolizumab; Oncology; Cancer Researchpembrolizumab
researchProduct

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is…

2006

BACKGROUND AND OBJECTIVES: This European Group for Blood and Marrow Transplantation (EBMT) multicentre randomized phase III study was designed to assess the safety and efficacy of CD34+ selection in newly diagnosed myeloma patients undergoing autologous transplantation. DESIGN AND METHODS: One hundred and eleven patients responsive to initial chemotherapy were randomized to receive CD34+ selected (arm A) or unselected PBPC (arm B) after conditioning with high-dose melphalan and TBI. ASO-PCR was used to assess purging efficacy and reinfused tumor load. Tumor load could be assessed in 59 patients. RESULTS: CD34+ selection gave a median tumor cell depletion of 2.2 logs (0.77-5.96). No tumor ce…

autologous transplantMelphalanOncologyAdultMaleRiskmedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentAntigens CD34Transplantation AutologousDexamethasoneDisease-Free SurvivalPostoperative ComplicationsRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineEuropean Group for Blood and Marrow TransplantatioAutologous transplantationHumansSurvival rateSurvival analysisMultiple myelomaAgedChemotherapyPeripheral Blood Stem Cell TransplantationHematologybusiness.industryBone Marrow PurgingHematologyCD34+ selectionMiddle Agedmedicine.diseasePrognosisSurvival AnalysisBone marrow purgingSurgerySurvival RateTreatment OutcomeDoxorubicinVincristineFemalebusinessMultiple Myelomamedicine.drugFollow-Up StudiesHaematologica
researchProduct

In vitro efficacy of praziquantel against the cercariae of Diplostomum sp., Rhipidocotyle fennica and R. campanula.

2009

biologyCampanulaVeterinary (miscellaneous)SnailsZoologyAnticestodal AgentsTrematode InfectionsAquatic Sciencebiology.organism_classificationAnticestodal AgentsSurvival AnalysisIn vitroPraziquantelPraziquantelRhipidocotyle fennicamedicineAnimalsBucephalidaeTrematodaTrematodamedicine.drugJournal of fish diseases
researchProduct

Survival analysis of three clones of Brachionus plicatilis (Rotifera)

1994

Age-specific survival schedules of females from three genetically different clones of Brachionus plicatilis were analyzed at several environmental conditions in the laboratory.

biologyEcologyEnergetic costZoologymacromolecular substancesAquatic ScienceBrachionusbiology.organism_classificationSurvival analysisHydrobiologia
researchProduct

Mortality in multiple sclerosis: a review.

2008

This work was undertaken to evaluate studies on mortality caused by multiple sclerosis (MS), to evaluate if useful inferences can be drawn from survival studies that can be applied to clinical practice. A literature search was carried out to find epidemiological studies on MS prognosis, survival, mortality and causes of death relevant to our aim. The World Health Organization (WHO) reports on worldwide cause-specific mortality were also considered. Studies were evaluated according to the duration of the follow-up study, the year of publication and the methodology used. We evaluated MS survival from a methodological point of view and considered if time trends could be drawn from study result…

cause of deathLife ExpectancyMultiple SclerosisTime Factorsmultiple sclerosiAge FactorsHumansepidemiologySettore MED/26 - NeurologiaSurvival Analysismortalitysurvivalprognosi
researchProduct

Evidence for a link between the Atlantic Multidecadal Oscillation and annual asthma mortality rates in the US

2019

AbstractAn association between climatic conditions and asthma mortality has been widely assumed. However, it is unclear whether climatic variations have a fingerprint on asthma dynamics over long time intervals. The aim of this study is to detect a possible correlation between climatic indices, namely the Atlantic Multidecadal Oscillation and Pacific Decadal Oscillation, and asthma mortality rates over the period from 1950 to 2015 in the contiguous US. To this aim, an analysis of non-stationary and non-linear signals was performed on time series of US annual asthma mortality rates, AMO and PDO indices to search for characteristic periodicities. Results revealed that asthma death rates evalu…

climate variabilityMale0301 basic medicinePeriodicityFuture studiesUS annual asthma death rateslcsh:Medicinedroughthuman health0302 clinical medicineChildlcsh:ScienceAtlantic OceanAMOClimate patternMultidisciplinaryMortality rateAtlantic Multidecadal OscillationChild PreschoolFemaleAdultAdolescentasthma mortalityBiologyArticle03 medical and health sciencesPDOAtlantic multidecadal oscillationmedicineAsthma mortalityHumansclimateSurvival analysisAsthmaModels StatisticalPacific Oceanlcsh:Rmedicine.diseaseSurvival AnalysisAsthma030104 developmental biologyRisk factors13. Climate actionNorth Americalcsh:QNorth Pacific; regime shifts; climate variabilityClimate sciences030217 neurology & neurosurgeryPacific decadal oscillationDemography
researchProduct

Correction: Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotoni…

2018

ABSTRACT Myotonic dystrophy (DM) is a dominantly inherited neuromuscular disorder caused by expression of mutant myotonin-protein kinase (DMPK) transcripts containing expanded CUG repeats. Pathogenic DMPK RNA sequesters the muscleblind-like (MBNL) proteins, causing alterations in metabolism of various RNAs. Cardiac dysfunction represents the second most common cause of death in DM type 1 (DM1) patients. However, the contribution of MBNL sequestration in DM1 cardiac dysfunction is unclear. We overexpressed Muscleblind (Mbl), the Drosophila MBNL orthologue, in cardiomyocytes of DM1 model flies and observed a rescue of heart dysfunctions, which are characteristic of these model flies and resem…

congenital hereditary and neonatal diseases and abnormalitiesRNA StabilityNeuroscience (miscellaneous)Medicine (miscellaneous)MuscleblindGeneral Biochemistry Genetics and Molecular BiologyImmunology and Microbiology (miscellaneous)AnimalsDrosophila ProteinsMyotonic DystrophyMyocytes CardiacRNA MessengerDaunorubicinCorrectionNuclear ProteinsReproducibility of ResultsHeartSurvival AnalysisAlternative SplicingDisease Models AnimalDrosophila melanogasterTrinucleotide repeat disorderDrosophilaTrinucleotide Repeat ExpansionResearch ArticleProtein BindingDisease Models & Mechanisms
researchProduct

ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma

2018

Abstract Background Rearrangements of RET are drivers of oncogenesis, traceable in different cancer types as papillary thyroid carcinoma (PTC), non-small cell lung cancer, colorectal or breast cancer. Anchored multiplex PCR based next-generation sequencing (NGS) can detect RET rearrangements involving previously unknown partner genes. Methods A sample of PTC underwent NGS, following detection of RET rearrangement by fluorescence in situ hybridization. Expression analysis of ANKRD26 and RET was performed for the tumor harboring ANKRD26-RET, for corresponding normal thyroid tissue and PTC tumors with representative genetic alterations (BRAFV600E, CCDC6-RET), complemented by a comparative sear…

congenital hereditary and neonatal diseases and abnormalitiesendocrine systemCancer Researchendocrine system diseasesBiologymedicine.disease_causeMetastasisThyroid carcinoma03 medical and health sciences0302 clinical medicineGeneticsmedicineHumansThyroid NeoplasmsneoplasmsMolecular BiologyGenemedicine.diagnostic_testProto-Oncogene Proteins c-retThyroidHigh-Throughput Nucleotide SequencingCancermedicine.diseaseSurvival Analysismedicine.anatomical_structureThyroid Cancer Papillary030220 oncology & carcinogenesisCancer researchIntercellular Signaling Peptides and ProteinsGene FusionCarcinogenesisTyrosine kinaseFluorescence in situ hybridizationCancer Genetics
researchProduct

Patient flows through Valhalla : A survival analysis in the context of short-term care institutions

2019

Master's thesis Business Administration BE501 - University of Agder 2019 Individuals experiencing functional decline may often require some form of assistance in order to reassume their activities of daily living. A common form of rehabilitation is a stay at a short-term institution, yet readmissions to such care facilities often occur. Home-based reablement has surfaced in Norway during the past ten years and aims to assist the user in reaching their own activity goals through a self-committed and intensive program, assisted by health care workers. The objective of this study isinquiring into the patient flows between home-nurse areas and short-term institutions in southern Norway over the…

duration modelingVDP::Medisinske Fag: 700::Helsefag: 800reablementBE501JEL classification: I18 J14 C41survival analysis
researchProduct